Projects
Global Vaccine Equity
The rapid development of safe and effective COVID-19 vaccines signifies a new era in the fight against the pandemic. Yet while there is incredible potential to save millions of lives globally, vaccine nationalism has curtailed equitable vaccine distribution; paving a path that has been described as a “catastrophic moral failure.” While countries such as the UK, Canada, and USA have secured contracts to vaccinate their populations several times over, it is estimated that 80% of people in low and middle income countries (LMICs) will not have access to the COVID-19 vaccine in 2021.
As COVID-19 continues to ravage populations around the world, vast and ongoing inequities in vaccine rollout have made clear the urgent need for global vaccine equity. In view of this issue, the Harvard Global Health Institute partnered with Ariadne Labs and the Harvard University Center for AIDS Research (CFAR) to elevate an evidence-based response to the challenges of equitable global vaccine allocation and distribution. In a three-part online webinar series, HGHI paired its robust experience in convening multidisciplinary experts with Ariadne Labs’ expertise in advancing innovative solutions for health care delivery and CFAR’s unique ability to drive innovative research around infectious diseases to elevate the insights of a diverse, multinational group of experts in vaccine equity.
In partnership with:
Righting the Path: Securing Global COVID-19 Vaccine Equity Webinar Series – Spring 2021
Righting the Path: Securing Global COVID-19 Vaccine Equity was a three-part webinar series hosted by the Harvard Global Health Institute, in partnership with Ariadne Labs and the Harvard University Center for AIDS Research (CFAR). The series aimed to foster dialogue between global experts about the overarching challenges to securing global COVID-19 vaccine equity, tangential threats to vaccine distribution including vaccine hesitancy, and approaches for correcting early failures that have already led to inequitable vaccine distribution.